Perrigo Company plc (NYSE:PRGO) Shares Sold by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC lowered its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 2,847,434 shares of the company's stock after selling 210,385 shares during the quarter. Perrigo comprises about 1.1% of Thompson Siegel & Walmsley LLC's portfolio, making the stock its 23rd largest position. Thompson Siegel & Walmsley LLC owned about 2.09% of Perrigo worth $73,208,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fore Capital LLC lifted its position in Perrigo by 35.7% during the 4th quarter. Fore Capital LLC now owns 38,000 shares of the company's stock worth $977,000 after acquiring an additional 10,000 shares during the period. Swiss National Bank raised its stake in shares of Perrigo by 0.6% during the 4th quarter. Swiss National Bank now owns 268,300 shares of the company's stock valued at $6,898,000 after buying an additional 1,700 shares during the last quarter. HighTower Advisors LLC raised its stake in shares of Perrigo by 8.5% during the 4th quarter. HighTower Advisors LLC now owns 13,307 shares of the company's stock valued at $342,000 after buying an additional 1,043 shares during the last quarter. AGF Management Ltd. purchased a new position in shares of Perrigo during the 4th quarter valued at about $2,363,000. Finally, Cooke & Bieler LP raised its stake in shares of Perrigo by 4.1% during the 4th quarter. Cooke & Bieler LP now owns 3,573,651 shares of the company's stock valued at $91,879,000 after buying an additional 139,650 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of research firms have weighed in on PRGO. Argus lowered Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Finally, Piper Sandler lowered Perrigo from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $33.00.

Insider Buying and Selling

In related news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the sale, the executive vice president now directly owns 33,666 shares in the company, valued at approximately $923,795.04. The trade was a 18.81 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.70% of the stock is currently owned by insiders.

Perrigo Price Performance

Shares of Perrigo stock traded up $1.01 on Monday, hitting $28.27. The company's stock had a trading volume of 1,795,376 shares, compared to its average volume of 1,421,598. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $33.46. The firm has a fifty day moving average price of $25.42 and a 200-day moving average price of $26.17. The company has a market capitalization of $3.86 billion, a price-to-earnings ratio of -24.16 and a beta of 0.48.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.20 billion. As a group, sell-side analysts anticipate that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Friday, March 7th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 4.10%. This is a boost from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. Perrigo's payout ratio is presently -92.80%.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.